{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:57:24Z","timestamp":1788955044103,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intramural Research Program of the NIH, National Institute of Environmental Health Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neulet.2016.12.049","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T08:47:16Z","timestamp":1482310036000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model"],"prefix":"10.1016","volume":"639","author":[{"given":"Gary N.Y.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily V.","family":"Mesev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.12.049_bib0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neulet.2016.12.049_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2016.12.049_bib0015","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2008.16","article-title":"Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GST\u03c0, at the blood-brain barrier","volume":"28","author":"Bauer","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neulet.2016.12.049_bib0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.106.029512","article-title":"Tumor necrosis factor \u03b1 and endothelin-1 increase p-glycoprotein expression and transport activity at the blood-brain barrier","volume":"71","author":"Bauer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2016.12.049_bib0025","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/mol.106.023796","article-title":"In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through p-glycoprotein up-regulation","volume":"70","author":"Bauer","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2016.12.049_bib0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2016.12.049_bib0035","doi-asserted-by":"crossref","first-page":"e0160520","DOI":"10.1371\/journal.pone.0160520","article-title":"Jr., RNAseq analyses identify tumor necrosis factor-mediated inflammation as a major abnormality in ALS spinal cord","volume":"11","author":"Brohawn","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.12.049_bib0040","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/jcbfm.2012.47","article-title":"ABC transporter function and regulation at the blood-spinal cord barrier","volume":"32","author":"Campos","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neulet.2016.12.049_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1471-4159.2011.07288.x","article-title":"Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells","volume":"118","author":"Chan","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.12.049_bib0050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2016.12.049_bib0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.110.168930","article-title":"Estrogen receptor \u03b2 signaling through phosphatase and tensin homolog\/phosphoinositide 3-kinase\/Akt\/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein","volume":"334","author":"Hartz","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2016.12.049_bib0060","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1523\/JNEUROSCI.0350-15.2016","article-title":"A\u03b240 reduces p-glycoprotein at the blood?brain barrier through the ubiquitin\u2013proteasome pathway","volume":"36","author":"Hartz","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.12.049_bib0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jnc.13389","article-title":"In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (PPAR\u03b1) at the blood-brain barrier","volume":"135","author":"Hoque","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.12.049_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.060","article-title":"ABC transporter-driven pharmacoresistance in amyotrophic lateral sclerosis","volume":"1607","author":"Jablonski","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.12.049_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","article-title":"Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS","volume":"47","author":"Jablonski","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2016.12.049_bib0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.141","article-title":"Inhibiting drug efflux transporters improves efficacy of ALS therapeutics","volume":"1","author":"Jablonski","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neulet.2016.12.049_bib0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.12.049_bib0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2007.04772.x","article-title":"Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier","volume":"103","author":"Milane","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.12.049_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2008.12.061","article-title":"Interactions between riluzole and ABCG2\/BCRP transporter","volume":"452","author":"Milane","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.12.049_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","article-title":"Regulation of ABC transporters blood-brain barrier the good, the bad, and the ugly","volume":"125","author":"Miller","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.neulet.2016.12.049_bib0105","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X16650216","article-title":"PPAR-alpha, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression","author":"More","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neulet.2016.12.049_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neulet.2007.01.028","article-title":"Identification of early disease progression in an ALS rat model","volume":"415","author":"Thonhoff","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.12.049_bib0115","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1523\/JNEUROSCI.2935-13.2014","article-title":"Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers","volume":"34","author":"Wang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.12.049_bib0120","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.12.049_bib0125","first-page":"3437","article-title":"Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells","volume":"119","author":"Zhong","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2016.12.049_bib0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","article-title":"Cytoprotective protein C pathways and implications for stroke and neurological disorders","volume":"34","author":"Zlokovic","year":"2011","journal-title":"Trends Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016309971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016309971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T10:06:19Z","timestamp":1718964379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016309971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"alternative-id":["S0304394016309971"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.12.049","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}